Common Premedications for IVIG Infusions
The standard premedication regimen for IVIG infusions should include acetaminophen and diphenhydramine or another H1-histamine antagonist to reduce the risk of infusion reactions. 1
Primary Premedication Recommendations
First-Line Premedications:
- Acetaminophen (650 mg orally)
- Diphenhydramine or other H1-histamine antagonist (25-50 mg)
These medications should be administered prior to starting the IVIG infusion to minimize the risk of infusion-related reactions, which occur in approximately 3-4% of infusions 2, 3.
Additional Medications to Have Available During Infusion
The following medications should be readily available at the bedside during IVIG administration:
- Continued acetaminophen (650 mg every 4 hours) as needed
- Indomethacin (50-75 mg every 6 hours) or equivalent NSAID for pain management
- H2 antagonists such as pantoprazole (40 mg) or famotidine (20 mg)
- Analgesics such as meperidine (25-50 mg) or hydromorphone for pain management
- Emergency medications: epinephrine and additional diphenhydramine for severe reactions
- Other medications as per institutional protocols 1
Management of Infusion Reactions
For Mild to Moderate Reactions:
- Stop the infusion immediately
- Switch to hydration fluid to keep vein open
- Monitor vital signs
- For symptom-specific treatment:
- Nausea: 5-HT3 antagonist (ondansetron 4-8 mg IV)
- Urticaria: Second-generation antihistamine (loratadine 10 mg orally or cetirizine 10 mg IV/oral)
- Mild hypotension: IV hydration with normal saline
For Severe Reactions:
- Administer epinephrine (0.3 mg IM) for anaphylaxis
- Consider IV corticosteroids (hydrocortisone 100-500 mg IV)
- Consider IV H2 antagonist (famotidine 20 mg IV)
- Provide respiratory support as needed 1
Important Considerations and Caveats
Avoid first-generation antihistamines during reactions: First-generation antihistamines like diphenhydramine can potentially convert minor infusion reactions into hemodynamically significant events by exacerbating hypotension, tachycardia, and sedation 1.
Corticosteroid use: Systemic corticosteroids are generally avoided as premedication for standard IVIG infusions unless specifically indicated for certain conditions 1.
Rechallenge after reactions: If a patient experiences a mild to moderate reaction that resolves completely, consider restarting the infusion at 50% of the initial rate after 15 minutes, with gradual increase if tolerated 1.
Risk factors for reactions: Patients with multiple drug allergies, prior reactions to IVIG, or asthma may be at higher risk for infusion reactions and may benefit from more aggressive premedication 1.
Monitoring requirements: Vital sign monitoring is recommended every 30 minutes during infusion, then hourly (±15 min) for 4 hours, and routinely thereafter 1.
While premedication is standard practice, some studies have questioned the effectiveness of routine premedication in preventing infusion reactions 4, 5. However, given the potential severity of reactions and the established safety profile of these premedications, the standard approach remains to premedicate patients receiving IVIG infusions.